Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 15, 280-284, June 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vermande-Van Eck, G. J.
Right arrow Articles by Chang, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vermande-Van Eck, G. J.
Right arrow Articles by Chang, C. H.

Action of Testosterone Propionate on the Output of Pituitary Gonadotrophins in Mice*

Gertrude J. Vermande-Van Eck and C. H. Chang

( Departments of Anatomy and Radiology, Yale University School of Medicine, New Haven, Conn.)

Testosterone propionate suppressed the augmented gonadotrophic hormone output of the pituitary of both x-radiated and gonadectomized mice, as determined by the response of intact parabionts.

Two series of experiments involving 47 and 52 pairs of mice in parabiosis were used. In a short-term experiment testosterone propionate (1.25 mg. weekly) restored the high output of pituitary gonadotrophins in castrated and x-rayed animals to normal levels. In a long-term experiment the same dose of testosterone propionate given weekly kept the gonadotrophic output within normal limits for periods up to 10 months.

Testosterone inhibited the abnormal release of pituitary gonadotrophins both after castration or x-radiation of mice. Why ovarian tumors still occur in x-rayed mice which are regularly injected with testosterone propionate cannot be explained by assuming an elevated exposure of the ovaries to gonadotrophins. In these animals other factors than overproduction of gonadotrophins must be responsible for the tumor formation.

* Part of this paper was presented before the annual meeting of the American Association for Cancer Research, New York City, April 11–13, 1952 (abstract published in Cancer Research, 12:254, 1952).

Supported by a grant from The Anna Fuller Fund, The Jane Coffin Childs Memorial Fund, and the National Cancer Institute, United States Public Health Service.

Received 12/ 3/54.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1955 by the American Association for Cancer Research.